Bibliography
- Sizova L : Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.Br. J. Clin. Pharmacol.66(2), 173–178 (2008).
- Van Der Bijl AE , Goekoop-RuitermanYP, De Vries-Bouwstra JK et al.: Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum.56(7), 2129–2134 (2007).
- Zhou H-F , Chan HW, Wickline SA, Lanza GM, Pham CT: αvβ3-targeted nanotherapy suppresses inflammatory arthritis in mice. Faseb J.23(9), 2978–2985 (2009).
- Duda DG , JainRK, WillettCG: Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.J. Clin. Oncol.25(26), 4033–4042 (2007).
- Culy C : Bevacizumab: antiangiogenic cancer therapy.Drugs Today (Barc)41(1), 23–36 (2005).
- Fukumura D , JainRK: Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.Microvasc. Res.74(2–3), 72–84 (2007).
- Winter PM , CaruthersSD, ZhangH, WilliamsTA, WicklineSA, LanzaGM: Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.JAAC Cardiovasc. Imaging1(5), 624–634 (2008).
- Adkison AM , RaptisSZ, KelleyDG, PhamCT: Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis.J. Clin. Invest.109(3), 363–371 (2002).
- Schnell MA , HardyC, HawleyM, PropertKJ, WilsonJM: Effect of blood collection technique in mice on clinical pathology parameters.Human Gene Ther.13(1), 155–161 (2002).
- Storgard CM , StupackDG, JonczykA, GoodmanSL, FoxRI, ChereshDA: Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist.J. Clin. Invest.103(1), 47–54 (1999).
- Bulte JWM , LanzaGM, FuhrhopRWet al.: Gd-DTPA perfluorocarbon emulsions as a novel paramagnetic particulate contrast medium: T1 and T2 relaxometry. Presented at: Proceedings of International Society for Magnetic Resonance in Medicine 6th Annual Meeting.Sydney, Australia, 18–24 April (1998) (Abstract 209).
- Lena N , ImbertAM, BrunetP, CanoJP, CarcassonneY: Kinetics of methotrexate and its metabolites in red blood cells.Cancer Drug Deliv.4(2), 119–127 (1987).
- Chan ES , CronsteinBN: Methotrexate – how does it really work?Nat. Rev. Rheumatol.6(3), 175–178 (2010).
- Varner JA , BrooksPC, ChereshDA: Review: The integrin αvβ3: angiogenesis and apoptosis.Cell Adhes. Commun.3(4), 367–374 (1995).
- Moulton KS , HellerE, KonerdingMA, FlynnE, PalinskiW, FolkmanJ: Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.Circulation99(13), 1726–1732 (1999).
- Brdlik CM , CrewsCM: A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases.J. Biol. Chem.279(10), 9475–9480 (2004).
- De Bandt M , GrossinM, WeberAJet al.: Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis.Arthritis Rheum.43(9), 2056–2063 (2000).
- Herbst RS , MaddenTL, TranHTet al.: Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer.J. Clin. Oncol.20(22), 4440–4447 (2002).
- Neurath MF , HildnerK, BeckerCet al.: Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): A mechanism for methotrexate-mediated immunosuppression.Clin. Exp. Immunol.115(1), 42–55 (1999).
- Szekanecz Z , BesenyeiT, ParaghG, KochAE: New insights in synovial angiogenesis.Joint Bone Spine77(1), 13–19 (2009).
- Szekanecz Z , BesenyeiT, SzentpeteryA, KochAE: Angiogenesis and vasculogenesis in rheumatoid arthritis.Curr. Opin. Rheum.22(3), 299–306 (2010).
Patent
- BRISTOL-MYERS SQUIBB PHARMA COMPANY: US6511648 (2003).
Website
- Image J: image processing and analysis in Java http://rsb.info.nih.gov/ij